Review launched after Harvard psychiatrist failed to disclose industry fundingBMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39609.364688.DB (Published 12 June 2008) Cite this as: BMJ 2008;336:1327
- Jeanne Lenzer
- 1New York
Findings that a leading Harvard professor of psychiatry failed to report substantial payments that he received from drug companies has caused Harvard Medical School, one of its affiliated hospitals, and the US National Institutes of Health (NIH) to come under fire.
An investigation by the US senator Charles Grassley showed that the psychiatrist, Joseph Biederman, and two of his colleagues, Thomas Spencer and Timothy Wilens, had altogether received more than $4.2m (£2.1m; €2.7m) from drug companies since 2000.